What does avkare — restructuring and other charges mean?

Captures costs associated with organizational realignment, facility closures, or significant changes in the AvKARE segment's business structure intended to improve long-term profitability. These charges are typically excluded from core operating metrics to provide a clearer view of ongoing business performance.

Amneal Pharmaceuticals, Inc. AMRX AvKARE — Restructuring and other charges

Other segment segments

Affordable Medicines

$2.2M—

Specialty

$347K+167%

Similar metrics at other companies

LHRestructuring and other charges

$31.8M+177%

CHRWAll Other and Corporate — Restructuring Charges

$1.65M—

BF.ARestructuring And Other Charges

$4.75M-68.3%

APDRestructuring and other charges

$0-100%

VFCActive — Other Restructuring Costs

$3.04M—

RPMCorporate And Other — Restructuring Charges

$1.52M—

Other financials

Income statement

See full

Revenue$722.5M+3.9%

Gross profit$320.1M+25.1%

Operating income$141.8M+41.3%

Net income$62.3M+411%

EPS (diluted)$0.19+375%

Balance sheet

See full

Cash & equivalents$197.7M+234%

Total debt$2.6B+17.7%

Total equity-$45.4M+65.5%

Total assets$3.5B+5.2%

Cash flow

See full

Operating cash flow-$26.7M-461%

CapEx$8.2M-37.9%

Free cash flow-$34.9M-507%

Valuation

See full

Market cap$5.17B+51.0%

Enterprise value$7.55B+33.4%

P/E42.4×—

P/S1.7×+0.5×

Profitability

See full

Gross margin38.7%+2.0pp

Operating margin14.3%+1.6pp

Net margin4%+3.6pp

FCF margin7.9%-1.0pp

Returns & leverage

See full

Return on equity-52.8%-12.7pp

Debt / equity127.9×+119×

Current ratio2.5×+1.1×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s avkare — restructuring and other charges.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s avkare — restructuring and other charges?: Amneal Pharmaceuticals, Inc. (AMRX) reported avkare — restructuring and other charges of $0 in Q1 2026.
What does avkare — restructuring and other charges mean?: Captures costs associated with organizational realignment, facility closures, or significant changes in the AvKARE segment's business structure intended to improve long-term profitability. These charges are typically excluded from core operating metrics to provide a clearer view of ongoing business performance.